Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study

Holländer-Mieritz, Cecilie; Vogelius, I.R.; Kristensen, Claus Andrup; Green, Allan; Rindum, J; Pappot, Helle

doi:10.2196/26096

Cited by 5 publications

(7 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Before initiating the current study, a study protocol was published in a peer-reviewed journal [18]. The adherence rate (wear time >12/h/d during the study period) of 31% was lower than we had anticipated.…”

Section: Discussionmentioning

confidence: 91%

“…In the OncoWatch 1.0 study, we established a framework for testing a smartwatch for home monitoring in a public healthcare hospital. In this study, we could not obtain the adherence rate to the smartwatch predefined in the study protocol [18]. Nevertheless, we gained novel knowledge on using smartwatches for collecting objective data in a patient group with HNC that is underrepresented in the studies of [10,20].…”

Section: Discussionmentioning

confidence: 98%

“…Further details of the protocol for the OncoWatch 1.0 study can be assessed in the published protocol article [18].…”

Section: Design and Patientsmentioning

confidence: 99%

See 2 more Smart Citations

Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer—Results from the OncoWatch 1.0 Study

Holländer-Mieritz

Steen-Olsen²,

Kristensen³

et al. 2023

Cancers

Self Cite

View full text Add to dashboard Cite

Background: Consumer wearables allow objective health data monitoring, e.g., of physical activity and heart rate, which might change over a cancer treatment course. Patients with head and neck cancer (HNC) receiving radiotherapy (RT) with curative intent typically experience side effects such as pain, decreased appetite, and dehydration, which may lead to hospitalizations. Therefore, health data monitoring could be important to understand a patient’s condition outside the hospital. The OncoWatch 1.0 study investigated the feasibility of using smartwatches for patients with HNC receiving RT. Methods: This study was a prospective, single-cohort feasibility study. The inclusion criteria were patients ≥ 18 years of age who planned to receive curatively intended radiotherapy for HNC. Consenting patients were asked to wear a smartwatch during RT and until two weeks after the end of RT. The primary endpoint was adherence. The secondary endpoints were data acquisition and variations in heart rate and physical activity. Results: Ten patients were included, with a median age of 62 years and eight males. The adherence rate for wearing the watch >12 h/d over the study period was 31%. The data acquisition rate was 61%. Conclusions: Although the primary endpoint was not reached, new knowledge has been established, including the secure data setup and key points that need to be addressed in future studies.

show abstract

Section: Discussionmentioning

confidence: 91%

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer—Results from the OncoWatch 1.0 Study

Holländer-Mieritz

Steen-Olsen²,

Kristensen³

et al. 2023

Cancers

Self Cite

View full text Add to dashboard Cite

show abstract

“…A power calculation is not required for this type of study because it is a feasibility study with no control group and no formal statistical hypothesis testing, and thus, the sample size is not driven by formal power calculations. This sample size corresponds to studies of the same nature in the literature [ 26 - 28 ].…”

Section: Methodsmentioning

confidence: 99%

Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background Studies have shown that there may be dissimilar perceptions on symptoms or side effects between patients with cancer and health care professionals. This may lead to symptomatic patients notifying the clinic irregularly or not telling the clinic at all. Wearables could help identify symptoms earlier. Patients with low socioeconomic status and less self-awareness of their health may benefit from this. A new design of wearables is a smart t-shirt that, with embedded sensors, provides measurement flows such as electrocardiogram, thoracic and abdominal respiration, and temperature. Objective This study evaluates the feasibility of using a smart t-shirt for home monitoring of biometric sensor data in adolescent and young adult and elderly patients during cancer treatment. Methods The OncoSmartShirt study is an explorative study investigating the feasibility of using the Chronolife smart t-shirt during cancer treatment. This smart t-shirt is designed with multiple fully embedded sensors and electrodes that engender 6 different measurement flows continuously. A total of 20 Danish patients with cancer ≥18 years old in antineoplastic treatment at Department of Oncology Rigshospitalet Denmark will be recruited from all cancer wards, whether patients are in curative or palliative care. Of these 20 patients, 10 (50%) will be <39 years old, defined as adolescent and young adult, and 10 (50%) will be patients >65 years old, defined as elderly. Consenting patients will be asked to wear a smart t-shirt daily for 2 weeks during their treatment course. Results The primary outcome is to determine if it is feasible to wear a smart t-shirt throughout the day (preferably 8 hours per day) for 2 weeks. Inclusion of patients started in March 2022. Conclusions The study will assess the feasibility of using the Chronolife smart t-shirt for home monitoring of vital parameters in patients with cancer during their treatment and bring new insights into how wearables and biometric data can be used as part of symptom or side-effect recognition in patients with cancer during treatment, with the aim to increase patients’ quality of life. Trial Registration ClinicalTrials.gov NCT05235594; https://beta.clinicaltrials.gov/study/NCT05235594 International Registered Report Identifier (IRRID) PRR1-10.2196/37626

show abstract

“…To reflect the present Danish experience with the feasibility of wearable sensors in oncology, a literature search was performed. Searching the scientific database PubMed using the search term: 'cancer and wearable sensor and Denmark and feasibility' revealed only two studies [48][49][50](case 1 (protocol [48] and result article [49]) and 2 (protocol article [50])) and a review on the topic performed by our research group [31]; the same two studies were identified when searching ClinicalTrials.gov using the same search term. Case 3 is a study designed by the author group but not yet performed.…”

Section: Case Presentationsmentioning

confidence: 99%

Experiences with Wearable Sensors in Oncology during Treatment: Lessons Learned from Feasibility Research Projects in Denmark

Pappot,

Steen-Olsen,

Holländer-Mieritz

2024

Diagnostics

Self Cite

View full text Add to dashboard Cite

Background: The fraction of elderly people in the population is growing, the incidence of some cancers is increasing, and the number of available cancer treatments is evolving, causing a challenge to healthcare systems. New healthcare tools are needed, and wearable sensors could partly be potential solutions. The aim of this case report is to describe the Danish research experience with wearable sensors in oncology reporting from three oncological wearable research projects. Case studies: Three planned case studies investigating the feasibility of different wearable sensor solutions during cancer treatment are presented, focusing on study design, population, device, aim, and planned outcomes. Further, two actual case studies performed are reported, focusing on patients included, data collected, results achieved, further activities planned, and strengths and limitations. Results: Only two of the three planned studies were performed. In general, patients found the technical issues of wearable sensors too challenging to deal with during cancer treatment. However, at the same time it was demonstrated that a large amount of data could be collected if the framework worked efficiently. Conclusion: Wearable sensors have the potential to help solve challenges in clinical oncology, but for successful research projects and implementation, a setup with minimal effort on the part of patients is requested.

show abstract

Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study

Cited by 5 publications

References 21 publications

Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer—Results from the OncoWatch 1.0 Study

Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer—Results from the OncoWatch 1.0 Study

Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study

Experiences with Wearable Sensors in Oncology during Treatment: Lessons Learned from Feasibility Research Projects in Denmark

Contact Info

Product

Resources

About